Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-22Clinical Trial Update: Healthier: Health Coaching for People With Rheumatoid Arthritis to Improve Mental Well-Being [NA]
A clinical trial is recruiting to evaluate a health coaching program designed to improve mental well-being in people with rheumatoid arthrit…
-
CLINICAL_TRIALS trial_result · 2026-01-22Clinical Trial Update: Combined Effect of Underwater Ultrasound [NA]
This clinical trial update reports the completed study evaluating underwater ultrasound for rheumatoid arthritis affecting the ankle and its…
-
FDA approval · 2026-01-21FDA Approved: CYCLOSPORINE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approved Upsher-Smith's original ANDA for generic cyclosporine.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: ROSA Total Knee Post Market Study EMEA [NA]
Zimmer Biomet's ROSA Total Knee post-market study in the EMEA region has completed and posted results.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Kinetics of Elimination of Methotrexate and Its Major Metabolite 7-OH-methotrexate for Observant Patients [NA]
This clinical trial update reports on the pharmacokinetics and elimination of methotrexate and its major metabolite 7-OH-methotrexate in pat…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Lipids, Inflammation, and CV Risk in RA
This clinical trial update reports on lipids, inflammation, and cardiovascular risk in rheumatoid arthritis; results have been posted.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Study of GS-0151 in Participants With Rheumatoid Arthritis [Phase 1]
Update on a Phase 1 clinical trial of GS-0151 in rheumatoid arthritis. The study is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Rotation or Change of Biotherapy After First Anti-TNF Treatment Failure for Rheumatoid Arthritis [Phase 4]
A Phase 4 clinical trial update evaluating rotation or switching of biotherapies after failure of initial anti-TNF therapy in rheumatoid art…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Persona OsseoTi Keel Compatibility Study (Total Knee Arthroplasty)
Clinical trial registry update showing ongoing recruitment for Zimmer Biomet's Persona OsseoTi Keel Compatibility Study in total knee arthro…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: UK Infinity, Post-Market Clinical Follow-up Study
This is a post-market clinical follow-up study of the Stryker UK Infinity device. It monitors long-term safety and performance in arthritis-…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: EF-M2 (Immutalon) Multiple Ascending Dose Study in Moderate-to-Severe Rheumatoid Arthritis [Phase 1, Phase 2]
EF-M2 (Immutalon) multiple ascending dose study in moderate-to-severe rheumatoid arthritis has completed (Phase 1/Phase 2).
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Clinical Study of (A-319) in the Treatment of Active Rheumatoid Arthritis [EARLY_Phase 1]
The document notes that the clinical study of A-319 for active rheumatoid arthritis is in early Phase 1 and currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
The study evaluated switching patients from original infliximab to its biosimilar in daily practice at Cochin Hospital, across rheumatoid ar…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Control Cohort CTRL COH [NA]
A status update for a control cohort in a Hospices Civils de Lyon trial, with recruitment ongoing for Parkinson's disease, amyotrophic later…
-
FDA approval · 2026-01-14FDA Approved: AVTOZMA — Supplemental Application (CELLTRION USA, Inc.)
FDA approves a supplemental application for AVTOZMA (tocilizumab) filed by Celltrion USA, Inc.
-
CLINICAL_TRIALS trial_result · 2026-01-14Clinical Trial Update: A Study of LNK01001 Capsule in Subjects With Active Rheumatoid Arthritis (COURAGE-RA) [Phase 3]
Phase 3 study COURAGE-RA evaluates LNK01001 Capsule in adults with active rheumatoid arthritis; the trial is currently active but not recrui…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Proximod, a Selective Sphingosine-1-phosphate Receptor 1 Modulator in Patients With Moderate-to-severe Active Rheumatoid Arthritis: a Double-blind, Randomised, Placebo-controlled, Phase 2 Trial. [Phase 2]
A Phase 2 double-blind, randomized, placebo-controlled trial evaluating Proximod, a selective S1P1 receptor modulator, in adults with modera…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Bone Density Change in Postmenopausal Rheumatoid Arthritis
A completed study from Istanbul University examining changes in bone density in postmenopausal women with rheumatoid arthritis and osteoporo…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Association Between Periodontitis and the Level of Anti-citrullinated Protein Antibodies in Rheumatoid Arthritis
A completed clinical trial examined whether periodontitis is associated with levels of anti-citrullinated protein antibodies in people with …
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases (Breakfree-1) [Phase 1]
Phase 1 Breakfree-1 trial evaluating CC-97540, a CD-19-targeted Nex-T CAR T cell therapy, for severe, refractory autoimmune diseases; the st…
-
EMA approval · 2026-01-12EMA Authorised: Xeljanz (tofacitinib) — Pfizer Europe MA EEIG
The EMA has authorised Xeljanz (tofacitinib) for rheumatoid arthritis, with Pfizer Europe MA EEIG as the marketing authorization holder.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: An Open-label Study of Cizutamig in Refractory Seropositive Rheumatoid Arthritis [Phase 1]
Open-label Phase 1 trial evaluating Cizutamig in patients with seropositive rheumatoid arthritis; currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial comparing oral upadacitinib to subcutaneous adalimumab in adults with moderate to severe rheumatoid arthritis to as…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Effect of Anti-inflammatory Diet in Rheumatoid Arthritis [NA]
This document updates a clinical trial evaluating the effects of an anti-inflammatory diet on rheumatoid arthritis. The study is currently r…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Study of F8IL10 Intra-articular Treatment in Rheumatoid Arthritis [Phase 1]
A Phase 1 clinical trial evaluating intra-articular F8IL10 for rheumatoid arthritis is currently recruiting.